Company intelligence / Profile preview
Dualitas Therapeutics
South San Francisco, California, United Statesdualitastx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dualitas Therapeutics is a preclinical-stage bispecific antibody company that launched from stealth in September 2025 with a $65 million Series A financing. The company's proprietary DualScreen discovery engine screens up to 100,000+ unique bispecific combinations to identify synergistic antibody pairs that leverage cell-surface proximity biology. The company's lead programs, DTX-103 (allergic disease) and DTX-102 (autoimmune disease), have demonstrated differentiated preclinical profiles when benchmarked against commercially available therapies, showing greater potency, enhanced efficacy, and faster onset of action compared to validated standard-of-care treatments.[3][6]
- Therapeutic areas
- ImmunologyPulmonologyGastroenterology
- Modalities
- Bispecific monoclonal antibody
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Eli Lilly and CompanyChugai Venture Fund
Beyond the preview
Go deeper on Dualitas Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dualitas Therapeutics.